We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

144 hedge funds and large institutions have $374M invested in Dynavax Technologies in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 55 increasing their positions, 43 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% less capital invested

Capital invested by funds: $376M → $374M (-$1.5M)

6% less call options, than puts

Call options by funds: $3.59M | Put options by funds: $3.81M

4.06% less ownership

Funds ownership: 80.42%76.36% (-4.1%)

13% less funds holding

Funds holding: 165144 (-21)

65% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 31

Holders
144
Holders Change
-21
Holders Change %
-12.73%
% of All Funds
2.55%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
11
Increased
55
Reduced
43
Closed
31
Calls
$3.59M
Puts
$3.81M
Net Calls
-$214K
Net Calls Change
-$1.03M
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$53.2M +$4.53M +1,000,000 +9%
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$48.5M
State Street
3
State Street
Massachusetts
$48.4M -$3.24M -715,811 -6%
BlackRock
4
BlackRock
New York
$36.4M +$113K +24,929 +0.3%
CC
5
Chicago Capital
Illinois
$25.7M +$8.38M +1,852,086 +47%
Vanguard Group
6
Vanguard Group
Pennsylvania
$22.7M -$433K -95,682 -2%
APM
7
Avidity Partners Management
Texas
$17.8M +$8.94M +1,975,000 +98%
PHS
8
PFM Health Sciences
California
$13.1M
William Blair & Company
9
William Blair & Company
Illinois
$9.72M +$662K +146,245 +7%
Goldman Sachs
10
Goldman Sachs
New York
$9.05M +$5.78M +1,276,851 +168%
RSCM
11
Rock Springs Capital Management
Maryland
$7.34M +$6.79K +1,500 +0.1%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$6.89M +$116K +25,529 +2%
EDRH
13
Edmond de Rothschild Holding
Switzerland
$6.54M +$905K +200,000 +16%
Ameriprise
14
Ameriprise
Minnesota
$5.85M -$3.57M -788,572 -37%
Northern Trust
15
Northern Trust
Illinois
$5.65M -$201K -44,446 -3%
RG
16
Redmile Group
California
$5.42M -$6.03M -1,331,776 -52%
RPAM
17
Rhenman & Partners Asset Management
Sweden
$4.12M
Macquarie Group
18
Macquarie Group
Australia
$3.4M
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$2.99M -$885K -195,505 -23%
Charles Schwab
20
Charles Schwab
California
$2.93M +$1.43K +315 +0%
Victory Capital Management
21
Victory Capital Management
Texas
$2.23M -$659K -145,553 -22%
Morgan Stanley
22
Morgan Stanley
New York
$2.02M +$177K +39,124 +9%
PAM
23
Panagora Asset Management
Massachusetts
$1.97M +$630K +139,122 +46%
Two Sigma Investments
24
Two Sigma Investments
New York
$1.89M -$3.95M -872,023 -67%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$1.88M +$13.6K +2,994 +0.7%

DVAX Hedge Fund Activity: Q4 2020 in Review

144 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q4 2020, worth a combined $374M — down 0.4% from $376M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of DVAX and 11 opened new positions — a net loss of 20 holders — while 43 trimmed existing stakes and 55 added.

The largest buyer was Avidity Partners Management, adding an estimated $8.94M. The largest seller was Citadel Advisors, cutting an estimated $9.18M.

  • 144 institutional investors held Dynavax Technologies (DVAX) as of Q4 2020, down from 165 in Q3 2020.
  • Funds reported $374M of Dynavax Technologies stock for Q4 2020, down 0.4% quarter-over-quarter.
  • 11 funds opened new Dynavax Technologies positions in Q4 2020 and 31 closed out, a net change of -20 holders.
  • The largest Dynavax Technologies buyer in Q4 2020 was Avidity Partners Management, an estimated $8.94M added.
  • The largest Dynavax Technologies seller in Q4 2020 was Citadel Advisors, an estimated $9.18M sold.

Based on aggregated 13F filings for Q4 2020.